TollereBio
Startup
TollereBio was founded to commercialize the BECC Technology planform for adjuvant development invented by Dr. Robert K. Ernst at the University of Maryland, Baltimore. The BECC platform enables quick and efficient engineering of lipid A mimetics for identification of new TLR4 adjuvants with customized immunostimulatory properties. Our team of experienced industry veterans is excited to offer accessible, cost-effective vaccine adjuvants that can have a positive impact on global human health.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events